|
| |
MGI Pharma dipeptidyl peptidase IV inhibitors Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
BioPortfolio - MGI Pharma - Profile
Azetidine-based inhibitors of dipeptidyl peptidase IV (DPP IV). ... KOTA Territory News: Nov 4 2008 10:39PM Matching: mgi pharma ...
http://www.bioportfolio.com/biocorporate/7006-MGI%2525252525...
|
Azetidine-based inhibitors of dipeptidyl peptidase IV (DPP IV).
Azetidine-based inhibitors of dipeptidyl peptidase IV (DPP IV). ... Senior Scientist II, MGI Pharma, 6611 Tributary Street, Baltimore, MD 21224, USA. Dana.
...
http://www.ncbi.nlm.nih.gov/pubmed/17352680...
|
BioPortfolio - Guilford Pharmaceuticals Incorporated - Profile
Department of Research, Guilford Pharmaceuticals Inc (now MGI Pharma),- Eur Urol . 2007 ... Dipeptidyl peptidase IV (DPP IV) is a ubiquitous membrane-bound ...
http://www.bioportfolio.com/biocorporate/4691-Guilford+Pharm...
|
2006 drug approvals: finding the niche : Article : Nature Reviews ...
Approvals originating from the top ten pharma companies accounted for less ... the first dipeptidyl peptidase 4 (DPP4) inhibitor to be approved and one of ...
http://www.nature.com/uidfinder/10.1038/nrd2247...
|
BioPortfolio - Guilford Pharmaceuticals Incorporated
7 Nov 2008 ... Department of Research, Guilford Pharmaceuticals Inc (now MGI ... Dipeptidyl peptidase IV (DPP IV) is a ubiquitous membrane-bound enzyme. ...
http://www.bioportfolio.com/biocorporate/4691-Guilford_Pharm...
|
Millennium ends Takeda's US shopping spree : Article : Nature ...
It is the latest signal that Japanese pharma is as intent as its European .... in Takeda's diabetes pipeline is SYR-472, a dipeptidyl peptidase inhibitor, ...
http://www.nature.com/nbt/journal/v26/n6/full/nbt0608-593.ht...
|
Patent alert
The research group lists collaboration with MGI. Pharma ..... are the dipeptidyl peptidase (DPP)-IV inhibitors that. were first disclosed in WO-2005000848. ...
http://www.biomedcentral.com/content/pdf/cd-898014.pdf...
|
January 7, 2008
MGI Pharma Inc. (NASDAQ:MOGN), Bloomington, Minn. Product: Palonosetron .... III trials of the oral, once-daily dipeptidyl peptidase-4 (DPP-4) inhibitor ...
http://www.biocentury.com/bcapp/BioCenturyCommon/CustomerSer...
|
Table of Contents
The What in the global life science, biotechnology and pharmaceutical sector, ... GLP-1 independently of dipeptidyl peptidase IV (DPP IV): New approaches to
...
http://www.bioportfolio.com/tableof.htm...
|
ERS/USDA Data - Agricultural Biotechnology Intellectual Property
(Tokyo, JP), Dipeptidyl peptidase IV from Xanthomonas maltophilia and ...... MGI PHARMA, INC. (Minnetonka, MN US), Vaccines against rift valley fever virus ...
http://www.ers.usda.gov/Data/agbiotechip/Data/Table26_Utilit...
|
|
